Salvage therapy with pentostatin for steroid-refractory graft-versus-host disease

被引：0
|
作者：
Leopardi, G [1 ]
Visani, G [1 ]
Giardini, C [1 ]
Sparaventi, G [1 ]
d'Adamo, F [1 ]
Nicolini, G [1 ]
Guiducci, B [1 ]
Barulli, S [1 ]
Malerba, L [1 ]
Lucesole, M [1 ]
Isidori, A [1 ]
机构：
[1] San Salvatore Hosp, Pesaro, Italy
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    Okamoto, M
    Okano, A
    Akamatsu, S
    Ashihara, E
    Inaba, T
    Takenaka, H
    Katoh, N
    Kishimoto, S
    Shimazaki, C
    LEUKEMIA, 2006, 20 (01) : 172 - 173
  • [42] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
  • [43] Leukotac® (anti-IL-2) as salvage treatment of steroid-refractory acute graft-versus-host disease
    Piñana, JL
    Valcárcel, D
    Martino, R
    Moreno, ME
    García, P
    Alvarez, I
    Sureda, A
    Briones, J
    Brunet, S
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S46 - S46
  • [44] Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
    Kim, Hyun Min
    Lee, Joonyeop
    Kim, Seokjin
    Lee, Jong Wook
    Kim, Hee-Je
    Cho, Young-Seok
    BLOOD RESEARCH, 2023, 58 (03) : 148 - 148
  • [45] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    M Okamoto
    A Okano
    S Akamatsu
    E Ashihara
    T Inaba
    H Takenaka
    N Katoh
    S Kishimoto
    C Shimazaki
    Leukemia, 2006, 20 : 172 - 173
  • [46] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Malard, Florent
    Huang, Xiao-Jun
    Sim, Joycelyn P. Y.
    LEUKEMIA, 2020, 34 (05) : 1229 - 1240
  • [47] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Florent Malard
    Xiao-Jun Huang
    Joycelyn P. Y. Sim
    Leukemia, 2020, 34 : 1229 - 1240
  • [48] Brentixumab vedotin for the treatment of steroid-refractory chronic graft-versus-host disease
    DeFilipp, Zachariah
    Li, Shuli
    Kempner, Maria
    Brown, Jami
    Del Rio, Candice
    Valles, Betsy
    Ballen, Karen
    Dey, Bimalangshu
    El-Jawahri, Areej
    McAfee, Steven
    Spitzer, Thomas
    Chen, Yi-Bin
    BONE MARROW TRANSPLANTATION, 2018, 53 : 398 - 398
  • [49] Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    Bordigoni, Pierre
    Dimicoli, Sophie
    Clement, Laurence
    Baumann, Cedric
    Salmon, Alexandra
    Witz, Francis
    Feugier, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 382 - 385
  • [50] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345